Effects of CPAP treatment on anxiety and depression in patients with OSAS Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017
Does persistent daytime hypersomnolence in CPAP treated patients with OSAS reflect comorbid narcolepsy or restless legs syndrome ? Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010
The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation Year: 2016
The analysis of depression symptoms in patients with sleep apnoea syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 254s Year: 2001
Obstructive sleep apnea syndrome and insomnia: The development of insomnia symptoms with CPAP treatment Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011
Evaluation quality of life, anxiety, and depression in patients with obstructive sleep syndrome before and after three and twelve months of continuous positive airway pressure therapy Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021
Long term effects of CPAP therapy in sleep apnea patients with metabolic syndrome Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Prevalence of anxiety disorder and depression in newly diagnosed obstructive sleep apnea patients Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea Year: 2016
Sleep apnoea, anxiety, depression and somatoform pain: a community-based high-risk sample Source: Eur Respir J 2012; 40: 400-407 Year: 2012
How to conduct a clinical assessment of patients with suspected sleep-related breathing disorders (SBD) Source: Procedure Video 2021: How to conduct a clinical assessment of patients with suspected sleep-related breathing disorders (SBD) Year: 2021
Insomnia, OSAS and CPAP treatment Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008
Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment Source: Eur Respir J 2013; 41: 593-600 Year: 2013
Night treatment with long acting ß2 agonists in mild COPD patients with sleep apnoea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 74s Year: 2007
Can we predict successful CPAP treatment in upper airways resistance syndrome? Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing? Year: 2013
Long term reduction of blood pressure in young and elderly hypertensive patients with sleep apnea syndrome treated with CPAP Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013
Incidence of asthma in patients with attention deficit hyperactivity disorder (ADHD) Source: Annual Congress 2005 - What is new in childhood respiratory epidemiology? Year: 2005
Severe asthma, panic disorder and depression Source: Eur Respir J 2005; 26: Suppl. 49, 8s Year: 2005
Effect of nCPAP-therapy to depressive symptoms in patients with obstructive sleep apnea Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010
Does personality change in obstructive sleep apnea (OSA) patients using CPAP? Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006
Hypertension among obstructive sleep apnea patients compared to controls. Two year change after starting treatment with CPAP Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013